FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097506413> ?p ?o ?g. }

• W2097506413 endingPage "1305" @default.
• W2097506413 startingPage "1295" @default.
• W2097506413 abstract "Clostridium difficile mediates intestinal inflammation by releasing toxin A (TxA), a potent enterotoxin. Cathelicidins (Camp as gene name, LL-37 peptide in humans and mCRAMP peptide in mice) are antibacterial peptides that also posses anti-inflammatory properties.To determine the role of cathelicidins in models of Clostridium difficile infection and TxA-mediated ileal inflammation and cultured human primary monocytes.Wild-type (WT) and mCRAMP-deficient (Camp(-/-)) mice were treated with an antibiotic mixture and infected orally with C difficile. Some mice were intracolonically given mCRAMP daily for 3 days. Ileal loops were also prepared in WT mice and treated with either saline or TxA and incubated for 4 h, while some TxA-treated loops were injected with mCRAMP.Intracolonic mCRAMP administration to C difficile-infected WT mice showed significantly reduced colonic histology damage, apoptosis, tissue myeloperoxidase (MPO) and tumour necrosis factor (TNF)α levels. Ileal mCRAMP treatment also significantly reduced histology damage, tissue apoptosis, MPO and TNFα levels in TxA-exposed ileal loops. WT and Camp(-/-) mice exhibited similar intestinal responses in both models, implying that C difficile/TxA-induced endogenous cathelicidin may be insufficient to modulate C difficile/TxA-mediated intestinal inflammation. Both LL-37 and mCRAMP also significantly reduced TxA-induced TNFα secretion via inhibition of NF-κB phosphorylation. Endogenous cathelicidin failed to control C difficile and/or toxin A-mediated inflammation and even intestinal cathelicidin expression was increased in humans and mice.Exogenous cathelicidin modulates C difficile colitis by inhibiting TxA-associated intestinal inflammation. Cathelicidin administration may be a new anti-inflammatory treatment for C difficile toxin-associated disease." @default.
• W2097506413 created "2016-06-24" @default.
• W2097506413 creator A5005344517 @default.
• W2097506413 creator A5008861715 @default.
• W2097506413 creator A5014760553 @default.
• W2097506413 creator A5025283381 @default.
• W2097506413 creator A5031938988 @default.
• W2097506413 creator A5041357685 @default.
• W2097506413 creator A5042304008 @default.
• W2097506413 creator A5050953582 @default.
• W2097506413 creator A5051870878 @default.
• W2097506413 creator A5053448553 @default.
• W2097506413 creator A5072814130 @default.
• W2097506413 creator A5073525946 @default.
• W2097506413 creator A5088772826 @default.
• W2097506413 creator A5089102027 @default.
• W2097506413 date "2012-07-03" @default.
• W2097506413 modified "2023-10-16" @default.
• W2097506413 title "The antimicrobial peptide cathelicidin modulates<i>Clostridium difficile</i>-associated colitis and toxin A-mediated enteritis in mice" @default.
• W2097506413 cites W141685425 @default.
• W2097506413 cites W1970985904 @default.
• W2097506413 cites W1973650764 @default.
• W2097506413 cites W1984382389 @default.
• W2097506413 cites W1988679328 @default.
• W2097506413 cites W1997834526 @default.
• W2097506413 cites W2001337739 @default.
• W2097506413 cites W2001507899 @default.
• W2097506413 cites W2019072949 @default.
• W2097506413 cites W2034280103 @default.
• W2097506413 cites W2034516137 @default.
• W2097506413 cites W2034752409 @default.
• W2097506413 cites W2063116767 @default.
• W2097506413 cites W2063224638 @default.
• W2097506413 cites W2065777365 @default.
• W2097506413 cites W2066921908 @default.
• W2097506413 cites W2071291247 @default.
• W2097506413 cites W2074283650 @default.
• W2097506413 cites W2082205311 @default.
• W2097506413 cites W2084951281 @default.
• W2097506413 cites W2085074249 @default.
• W2097506413 cites W2088186083 @default.
• W2097506413 cites W2095040861 @default.
• W2097506413 cites W2098306468 @default.
• W2097506413 cites W2101339759 @default.
• W2097506413 cites W2108174511 @default.
• W2097506413 cites W2109120401 @default.
• W2097506413 cites W2114182108 @default.
• W2097506413 cites W2124604126 @default.
• W2097506413 cites W2127067932 @default.
• W2097506413 cites W2131353762 @default.
• W2097506413 cites W2136993229 @default.
• W2097506413 cites W2139057316 @default.
• W2097506413 cites W2140539199 @default.
• W2097506413 cites W2143154387 @default.
• W2097506413 cites W2151116384 @default.
• W2097506413 cites W2152154463 @default.
• W2097506413 cites W2160939594 @default.
• W2097506413 cites W2393115371 @default.
• W2097506413 doi "https://doi.org/10.1136/gutjnl-2012-302180" @default.
• W2097506413 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3737259" @default.
• W2097506413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22760006" @default.
• W2097506413 hasPublicationYear "2012" @default.
• W2097506413 type Work @default.
• W2097506413 sameAs 2097506413 @default.
• W2097506413 citedByCount "80" @default.
• W2097506413 countsByYear W20975064132013 @default.
• W2097506413 countsByYear W20975064132014 @default.
• W2097506413 countsByYear W20975064132015 @default.
• W2097506413 countsByYear W20975064132016 @default.
• W2097506413 countsByYear W20975064132017 @default.
• W2097506413 countsByYear W20975064132018 @default.
• W2097506413 countsByYear W20975064132019 @default.
• W2097506413 countsByYear W20975064132020 @default.
• W2097506413 countsByYear W20975064132021 @default.
• W2097506413 countsByYear W20975064132022 @default.
• W2097506413 countsByYear W20975064132023 @default.
• W2097506413 crossrefType "journal-article" @default.
• W2097506413 hasAuthorship W2097506413A5005344517 @default.
• W2097506413 hasAuthorship W2097506413A5008861715 @default.
• W2097506413 hasAuthorship W2097506413A5014760553 @default.
• W2097506413 hasAuthorship W2097506413A5025283381 @default.
• W2097506413 hasAuthorship W2097506413A5031938988 @default.
• W2097506413 hasAuthorship W2097506413A5041357685 @default.
• W2097506413 hasAuthorship W2097506413A5042304008 @default.
• W2097506413 hasAuthorship W2097506413A5050953582 @default.
• W2097506413 hasAuthorship W2097506413A5051870878 @default.
• W2097506413 hasAuthorship W2097506413A5053448553 @default.
• W2097506413 hasAuthorship W2097506413A5072814130 @default.
• W2097506413 hasAuthorship W2097506413A5073525946 @default.
• W2097506413 hasAuthorship W2097506413A5088772826 @default.
• W2097506413 hasAuthorship W2097506413A5089102027 @default.
• W2097506413 hasBestOaLocation W20975064132 @default.
• W2097506413 hasConcept C17991360 @default.
• W2097506413 hasConcept C203014093 @default.
• W2097506413 hasConcept C2775862500 @default.
• W2097506413 hasConcept C2776914184 @default.
• W2097506413 hasConcept C2777379352 @default.
• W2097506413 hasConcept C2994496256 @default.

• next